Zobrazeno 1 - 10 of 25 pro vyhledávání: '"Kaori Kusuda"'
1
Akademický článek
Effectiveness of Pharmacist–Physician Collaborative Management for Patients With Idiopathic Pulmonary Fibrosis Receiving Pirfenidone
Autor: Yukari Satsuma, Hiroaki Ikesue, Kaori Kusuda, Mami Maeda, Nobuyuki Muroi, Ryobu Mori, Mariko Kogo, Ryosuke Hirabayashi, Kazuma Nagata, Atsushi Nakagawa, Ryo Tachikawa, Keisuke Tomii, Tohru Hashida
Publikováno v: Frontiers in Pharmacology, Vol 11 (2020)
Background: Pirfenidone is an anti-fibrotic agent used to treat patients with idiopathic pulmonary fibrosis (IPF). Managing adverse drug events and ensuring compliance with pirfenidone treatment for a prolonged period are important to reduce the rate
Externí odkaz: https://doaj.org/article/7b917075f63945708504f33124da4092
Zobrazit plný text záznamu
5
Development of a Surgical Sponge Counting System Using Radiographic Images
Autor: Kiyohito Tanaka, Shinichi Tanaka, Kazuhiko Yamashita, Yuji Ohta, Kaori Kusuda
Publikováno v: Surgical Innovation
Background. Retention of surgical sponges in patients is a relatively frequent medical malpractice. To prevent it, the surgical sites are scanned using X-ray. However, using radiography in the operation room induces X-ray exposure for both patients a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd6b73195d4b692bdeca7ae1f57fab8e
http://europepmc.org/articles/PMC7890693
Zobrazit plný text záznamu
6
Evaluation of the usefulness of protocol‐based pharmacist‐facilitated laboratory monitoring to ensure the safety of immune checkpoint inhibitors in patients with lung cancer
Autor: Takeshi Morimoto, Nobuyuki Muroi, Keisuke Tomii, Hiroaki Ikesue, Rieko Miura, Yoshio Masuda, Fuki Nishiwaki, Masaki Hirabatake, Tohru Hashida, Daichi Fujimoto, Kaori Kusuda, Yukari Satsuma
Publikováno v: Journal of Clinical Pharmacy and Therapeutics
What is known and objective Immune checkpoint inhibitors can cause immune‐related adverse events (irAEs). Improved monitoring systems for irAEs, which include laboratory tests by a qualified multidisciplinary team, might prevent patients from irAE
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::225b2a09f03810a693ae45b9d9469024
https://doi.org/10.1111/jcpt.13207
Zobrazit plný text záznamu
8
Current Landscape of Sonodynamic Therapy for Treating Cancer
Autor: Toshihiro Yamaguchi, Shuji Kitahara, Kaori Kusuda, Jun Okamoto, Yuki Horise, Ken Masamune, Yoshihiro Muragaki
Publikováno v: Cancers, Vol 13, Iss 6184, p 6184 (2021)
Cancers
Simple Summary Recently, ultrasound has advanced in its treatment opportunities. One example is sonodynamic therapy, a minimally invasive anti-cancer therapy involving a chemical sonosensitizer and focused ultrasound. The combination of the ultrasoun
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0d7a1b50efea4b5ad7d33249662044b
https://www.mdpi.com/2072-6694/13/24/6184
Zobrazit plný text záznamu
10
Effectiveness of Pharmacist–Physician Collaborative Management for Patients With Idiopathic Pulmonary Fibrosis Receiving Pirfenidone
Autor: Atsushi Nakagawa, Ryobu Mori, Kazuma Nagata, Ryosuke Hirabayashi, Nobuyuki Muroi, Tohru Hashida, Yukari Satsuma, Hiroaki Ikesue, Mami Maeda, Mariko Kogo, Ryo Tachikawa, Keisuke Tomii, Kaori Kusuda
Publikováno v: Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 11 (2020)
Background: Pirfenidone is an anti-fibrotic agent used to treat patients with idiopathic pulmonary fibrosis (IPF). Managing adverse drug events and ensuring compliance with pirfenidone treatment for a prolonged period are important to reduce the rate
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7977fe513dec9fbe8a77ee20298e79b
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje